Semprus BioSciences closes $18 million Series B round

December 13, 2010 by MassDevice staff

Semprus BioSciences Corp. reeled in $18 million in Series B financing for its nanotech medical device coating.

Semprus CEO David Lucchino told MassDevice that the company will use the proceeds to build a team of "been there, done that" medical device executives and to scale up its manufacturing operations.

"Investor expectations with this round of funding are that we would gain regulatory and clinicial clarity, along with having an initial product in hand to start initial sales. We're looking at the next 24 months as being that window," Lucchino told us.

Permalink